- Home
- GPGI vs INDV Comparison
GPGI vs INDV Comparison
Compare GPGI & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPGI | INDV |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | 977 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.4B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | GPGI | INDV |
|---|---|---|
| Price | $15.15 | $40.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.5M | ★ 1.6M |
| Earning Date | 05-07-2026 | 06-08-2026 |
| Dividend Yield | ★ 0.07% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $768.10 | N/A |
| Revenue Next Year | $126.25 | N/A |
| P/E Ratio | ★ N/A | $58.46 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $11.22 | $15.48 |
| 52 Week High | $25.66 | $42.81 |
Technical Indicators
Market Signals| Indicator | GPGI | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 54.25 | 60.37 |
| Support Level | $11.30 | $39.20 |
| Resistance Level | $17.50 | $42.81 |
| Average True Range (ATR) | 0.84 | 1.51 |
| MACD | -0.15 | -0.12 |
| Stochastic Oscillator | 31.06 | 51.25 |
Price Performance
Historical ComparisonAbout GPGI GPGI Inc.
GPGI Inc is a diversified holding permanent capital platform designed to acquire, own, and scale high-quality businesses that hold great positions in good industries.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).